Your browser doesn't support javascript.
loading
Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.
McFarland, Braden C; Marks, Margaret P; Rowse, Amber L; Fehling, Samuel C; Gerigk, Magda; Qin, Hongwei; Benveniste, Etty N.
Affiliation
  • McFarland BC; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Marks MP; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Rowse AL; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Fehling SC; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Gerigk M; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Qin H; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Benveniste EN; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
Oncotarget ; 7(15): 20621-35, 2016 Apr 12.
Article in En | MEDLINE | ID: mdl-26967393

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / T-Lymphocytes, Regulatory / Myeloid Cells / Suppressor of Cytokine Signaling 3 Protein / Glioma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Oncotarget Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / T-Lymphocytes, Regulatory / Myeloid Cells / Suppressor of Cytokine Signaling 3 Protein / Glioma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Oncotarget Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States